BIM
MDCO

BlackRock Investment Management’s Medicines Co MDCO Stock Holding History

BlackRock Investment Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$11.8M Buy
348,187
+62,652
+22% +$2.22M 0.01% 1000
2016
Q3 		$10.8M Buy
285,535
+1,123
+0.4% +$42.3K 0.01% 956
2016
Q2 		$9.56M Buy
284,412
+6,296
+2% +$222K 0.01% 988
2016
Q1 		$8.84M Buy
278,116
+3,931
+1% +$128K 0.01% 1005
2015
Q4 		$10.2M Buy
274,185
+2,400
+0.9% +$90.7K 0.01% 927
2015
Q3 		$10.3M Sell
271,785
-420
-0.2% -$14.7K 0.01% 908
2015
Q2 		$7.79M Buy
272,205
+53,337
+24% +$1.49M 0.01% 1175
2015
Q1 		$6.13M Buy
218,868
+4,087
+2% +$115K 0.01% 1238
2014
Q4 		$5.94M Sell
214,781
-1,993
-0.9% -$49.4K 0.01% 1247
2014
Q3 		$4.84M Buy
216,774
+986
+0.5% +$25K 0.01% 1356
2014
Q2 		$6.27M Buy
215,788
+5,397
+3% +$144K 0.01% 1245
2014
Q1 		$5.98M Buy
210,391
+1,964
+0.9% +$65K 0.01% 1240
2013
Q4 		$8.05M Sell
208,427
-1,715
-0.8% -$61.3K 0.01% 1034
2013
Q3 		$7.04M Buy
210,142
+32,451
+18% +$1.03M 0.01% 1076
2013
Q2 		$5.47M Buy
+177,691
New +$5.94M 0.01% 1150

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

BlackRock Investment Management's MDCO Position: Q4 2016 in Review

BlackRock Investment Management increased its Medicines Co (MDCO) stake by 22% in Q4 2016, buying an estimated $2.22M and bringing the position to 348,187 shares worth $11.8M. The position accounts for 0.01% of the portfolio, ranked #1000.

BlackRock Investment Management first reported a position in MDCO in Q2 2013 and has held it in 15 quarters since. 195 funds tracked by Wall St. Rank hold MDCO as of Q4 2016.

  • BlackRock Investment Management held 348,187 shares of Medicines Co worth $11.8M as of Q4 2016.
  • BlackRock Investment Management bought 62,652 Medicines Co shares in Q4 2016, an estimated $2.22M.
  • Medicines Co made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1000 holding.
  • BlackRock Investment Management first reported a position in Medicines Co in Q2 2013 and has held it in 15 quarters since.
  • 195 funds tracked by Wall St. Rank held Medicines Co as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.